Immunology

Immune therapies against chronic hepatitis B

Hepatitis B virus (HBV) infection is global in nature and induces several liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died ...

Diseases, Conditions, Syndromes

NIH updates Hepatitis B Strategic Research Plan

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, ...

Diseases, Conditions, Syndromes

A roadmap for the future of hepatitis B therapy development

Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...

Diseases, Conditions, Syndromes

Review shines a light on the overlooked virus, hepatitis D

Viral hepatitis is a serious health condition that affects the liver. While hepatitis B and C viruses are commonly targeted by public health measures aiming to reduce the disease burden, there is another, less commonly known ...

Diseases, Conditions, Syndromes

When to get a COVID-19 booster

If you recently had COVID-19, you may be wondering if you should delay getting your booster. We asked James Moy, MD, an immunologist in the Department of Internal Medicine at RUSH who is studying the antibody levels and duration ...

page 4 from 20